Nucleic Acids Research, 2002, Vol. 30, No. 6 1325-1332
© 2002 Oxford University Press
Involvement of conserved histidine, lysine and tyrosine residues in the mechanism of DNA cleavage by the caspase-3 activated DNase CAD
Institut für Biochemie, Justus-Liebig-Universität, Heinrich Buff Ring 58, 35392 Giessen, Germany and 1Department of Genetics, Kazan State University, Kremlevskaja 18, 420008 Kazan, Russian Federation
The caspase-activated DNase (CAD) is involved in DNA degradation during apoptosis. Chemical modification of murine CAD with the lysine-specific reagent 2,4,6-trinitrobenzenesulphonic acid and the tyrosine-specific reagent N-acetylimidazole leads to inactivation of the nuclease, indicating that lysine and tyrosine residues are important for DNA cleavage by this enzyme. The presence of DNA or the inhibitor ICAD-L protects the enzyme from modification. Amino acid substitution in murine CAD of lysines and tyrosines conserved in CADs from five different species leads to variants with little if any catalytic activity, but unaltered DNA binding (K155Q, K301Q, K310Q, Y247F), with the exception of Y170F, which retains wild-type activity. Similarly, as observed for the previously characterised H242N, H263N, H308N and H313N variants, the newly introduced His
Asp/Glu or Arg exchanges lead to variants with <1% of wild-type activity, with two exceptions: H313R shows wild-type activity, and H308D at pH 5.0 exhibits 
5% of wild-type activity at this pH. Y170F and H313R produce a specific pattern of fragments, different from wild-type CAD, which degrades DNA non-specifically. The recombinant nuclease variants produced in Escherichia coli were tested for their ability to form nucleolytically active oligomers. They did not show any significant deviation from the wild-type enzyme. Based on these and published data possible roles of the amino acid residues under investigation are discussed.
* To whom correspondence should be addressed. Tel: +49 641 99 35404; Fax: +49 641 99 35409; Email: gregor.meiss{at}chemie.bio.uni-giessen.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Xiao, P. Widlak, and W. T. Garrard Engineered apoptotic nucleases for chromatin research Nucleic Acids Res., July 26, 2007; 35(13): e93 - e93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Reh, C. Korn, O. Gimadutdinow, and G. Meiss Structural Basis for Stable DNA Complex Formation by the Caspase-activated DNase J. Biol. Chem., December 16, 2005; 280(50): 41707 - 41715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Korn, S. R. Scholz, O. Gimadutdinow, R. Lurz, A. Pingoud, and G. Meiss Interaction of DNA Fragmentation Factor (DFF) with DNA Reveals an Unprecedented Mechanism for Nuclease Inhibition and Suggests That DFF Can Be Activated in a DNA-bound State J. Biol. Chem., February 18, 2005; 280(7): 6005 - 6015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Widlak, J. Lanuszewska, R. B. Cary, and W. T. Garrard Subunit Structures and Stoichiometries of Human DNA Fragmentation Factor Proteins before and after Induction of Apoptosis J. Biol. Chem., July 11, 2003; 278(29): 26915 - 26922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Scholz, C. Korn, O. Gimadutdinow, M. Knoblauch, A. Pingoud, and G. Meiss The effect of ICAD-S on the formation and intracellular distribution of a nucleolytically active caspase-activated DNase Nucleic Acids Res., July 15, 2002; 30(14): 3045 - 3051. [Abstract] [Full Text] [PDF]
|
|